Beam reports Q3 2026 results, outlines pipeline timelines for risto-cel, BEAM-302, BEAM-304Nov 3Quarterly updateBeam Therapeutics Inc.
Beam doses first patient in pivotal BEAM-302 cohort, updates PKU and sickle cell timelinesAug 4Quarterly updateBeam Therapeutics Inc.